LONDON--(BUSINESS WIRE)--RWS Group is pleased to announce that Sheena Dempsey has been selected as the new Chief Executive Officer of Corporate Translations, Inc., effective August 30, 2016. Sheena succeeds Mary Gawlicki, who along with Ted Gawlicki founded Corporate Translations in 1990 to fulfill the demand for high quality translation services in the life science industry. RWS Group’s medical translation division was integrated into Corporate Translations this year as part of the acquisition. Sheena will lead the RWS Life Science Division into its next phase of global success under the Corporate Translations brand.
Andrew Brode, Chairman of RWS Holdings stated, “I am very pleased to have Sheena as a member of the RWS Group and Corporate Translations. I know that Sheena’s long-standing experience in the translation industry and pharmaceutical expertise will be a huge asset to Corporate Translations.”
Sheena Dempsey is not a stranger to either the language services or life science industries. For over 20 years, she has accumulated in-depth knowledge of translation services, including extensive experience in operational management, business development, and the specific requirements of the life science sector. She started her career at Siemens before advancing into her executive roles within Lionbridge in both Ireland and the United States. Before joining Corporate Translations, Sheena served as General Manager and Vice President of the Lionbridge Life Sciences Division with global responsibility for developing multilingual solutions for global life sciences sponsors.
About RWS:
RWS Group is a global leader in language services, employing over 750 staff worldwide. It is a leading provider of intellectual property support services and high level technical translation and localization services for clients in the engineering, electronics, pharmaceutical and life sciences, chemical, legal and financial industries.
About Corporate Translations
Corporate Translations, a proud member of the RWS Group, was founded in 1990 specifically to answer the demand for high quality translations solutions in the pharmaceutical, biotech, and medical device industries. With over 26 years of acquired knowledge in these highly regulated industries, and the recent integration with the RWS Group’s medical translation division, the company has become a recognized expert in managing translation and linguistic validation projects for the world’s top pharmaceutical and biotech companies.
For more information about Corporate Translations, please call 860-727-6000 or visit www.corptransinc.com.
